Centene's Q2 Premiums Climb 3.6% Amid Strong Service Revenue Growth
Ticker: CNC · Form: 10-Q · Filed: 2025-07-25T00:00:00.000Z
Sentiment: bullish
Topics: Healthcare, Managed Care, Q2 Earnings, Revenue Growth, Financial Performance, Investor Insight, SEC Filing
Related Tickers: CNC, UNH, ELV
TL;DR
**Centene's Q2 numbers show solid premium and service revenue growth, making it a stable bet in a volatile healthcare market.**
AI Summary
Centene Corp (CNC) reported robust financial performance for the second quarter ended June 30, 2025, with healthcare premiums for the three months increasing to $37.5 billion from $36.2 billion in the prior year period, representing a 3.6% growth. For the six months ended June 30, 2025, healthcare premiums reached $74.8 billion, up from $72.1 billion in the same period of 2024, a 3.7% increase. Service revenues also saw a significant rise, hitting $1.2 billion for the second quarter of 2025 compared to $1.1 billion in Q2 2024, an 9.1% increase. The company's total equity attributable to Centene shareholders stood at $20.5 billion as of June 30, 2025, a slight decrease from $20.7 billion at December 31, 2024. Retained earnings increased to $24.1 billion by June 30, 2025, from $23.6 billion at December 31, 2024, indicating strong profitability. The company's strategic outlook remains focused on expanding its managed care offerings and optimizing operational efficiency, despite a slight reduction in treasury stock from $14.9 billion to $14.8 billion over the six-month period.
Why It Matters
Centene's consistent growth in healthcare premiums and service revenue signals strong demand for its managed care offerings, which is crucial for investors seeking stable returns in the healthcare sector. This performance suggests Centene is effectively navigating competitive pressures from rivals like UnitedHealth Group and Elevance Health, maintaining its market position. For employees, this indicates job security and potential for growth within a thriving company. Customers benefit from continued access to Centene's health plans, while the broader market sees a healthy, competitive landscape in managed care.
Risk Assessment
Risk Level: low — The risk level is low due to consistent growth in key revenue streams. Healthcare premiums increased by 3.6% in Q2 2025 to $37.5 billion, and service revenues grew by 9.1% to $1.2 billion. Retained earnings also saw a healthy increase from $23.6 billion to $24.1 billion, demonstrating financial stability.
Analyst Insight
Investors should consider Centene (CNC) as a stable long-term holding given its consistent revenue growth and strong retained earnings. The company's ability to increase both healthcare premiums and service revenues in a competitive market suggests effective management and a resilient business model.
Financial Highlights
- revenue
- $37.5B
- revenue Growth
- +3.6%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Healthcare Premiums | $37.5B | +3.6% |
| Healthcare Premiums | $74.8B | +3.7% |
| Service Revenues | $1.2B | +9.1% |
Key Numbers
- $37.5B — Q2 2025 Healthcare Premiums (Increased 3.6% from Q2 2024)
- $74.8B — Six-Month Healthcare Premiums (Increased 3.7% from prior year period)
- $1.2B — Q2 2025 Service Revenues (Increased 9.1% from Q2 2024)
- $24.1B — Retained Earnings (Increased from $23.6B at Dec 31, 2024)
- $20.5B — Total Equity (Slight decrease from $20.7B at Dec 31, 2024)
Key Players & Entities
- CENTENE CORP (company) — filer of the 10-Q
- UnitedHealth Group (company) — competitor
- Elevance Health (company) — competitor
- $37.5 billion (dollar_amount) — healthcare premiums for Q2 2025
- $36.2 billion (dollar_amount) — healthcare premiums for Q2 2024
- $74.8 billion (dollar_amount) — healthcare premiums for six months ended June 30, 2025
- $72.1 billion (dollar_amount) — healthcare premiums for six months ended June 30, 2024
- $1.2 billion (dollar_amount) — service revenues for Q2 2025
- $1.1 billion (dollar_amount) — service revenues for Q2 2024
- $24.1 billion (dollar_amount) — retained earnings as of June 30, 2025
FAQ
What were Centene's healthcare premiums for the second quarter of 2025?
Centene's healthcare premiums for the second quarter ended June 30, 2025, were $37.5 billion, marking a 3.6% increase from $36.2 billion in the same period of 2024.
How did Centene's service revenues perform in Q2 2025?
Centene's service revenues for the second quarter of 2025 reached $1.2 billion, an increase of 9.1% compared to $1.1 billion reported in the second quarter of 2024.
What is Centene's total equity as of June 30, 2025?
As of June 30, 2025, Centene's total equity attributable to Centene shareholders was $20.5 billion, a slight decrease from $20.7 billion at December 31, 2024.
Did Centene's retained earnings change in the first half of 2025?
Yes, Centene's retained earnings increased to $24.1 billion by June 30, 2025, up from $23.6 billion at December 31, 2024, indicating strong profitability.
What are the key drivers of Centene's revenue growth?
The key drivers of Centene's revenue growth are the consistent increase in healthcare premiums, which grew 3.6% in Q2 2025, and a significant 9.1% rise in service revenues.
What are the primary risks for Centene based on this filing?
Based on the provided data, the primary risks appear low due to consistent revenue growth and strong retained earnings. No specific new or elevated risks were highlighted in the summary data.
How does Centene's performance impact investors?
Centene's strong performance, with growing premiums and service revenues, suggests stability and potential for continued returns, making it an attractive option for investors seeking a reliable healthcare stock.
What is Centene's strategic outlook for the remainder of 2025?
Centene's strategic outlook remains focused on expanding its managed care offerings and optimizing operational efficiency, building on the strong financial results of the first half of 2025.
How does Centene compare to its competitors in Q2 2025?
While specific competitor data isn't in the filing, Centene's 3.6% premium growth and 9.1% service revenue growth suggest it is maintaining a competitive edge in the managed care market against rivals like UnitedHealth Group and Elevance Health.
What was the change in Centene's treasury stock?
Centene's treasury stock saw a slight reduction from $14.9 billion at December 31, 2024, to $14.8 billion as of June 30, 2025.
Industry Context
Centene operates in the highly competitive managed care sector, which is characterized by evolving regulatory landscapes and a focus on government-sponsored healthcare programs like Medicare and Medicaid. Industry trends emphasize value-based care, operational efficiency, and expanding digital health capabilities to manage costs and improve member outcomes.
Regulatory Implications
As a major provider of government-sponsored health plans, Centene is subject to extensive regulation by federal and state agencies. Changes in healthcare policy, reimbursement rates, and compliance requirements can significantly impact financial performance and operational strategies.
What Investors Should Do
- [object Object]
- [object Object]
- [object Object]
Key Dates
- 2025-06-30: Quarterly Report Filing (10-Q) — Provides updated financial performance and operational details for the period ending June 30, 2025.
- 2025-07-25: 10-Q Filing Date — Official date the Q2 2025 10-Q was filed with the SEC.
- 2024-12-31: Year-End Reporting Reference — Used as a comparison point for equity and retained earnings changes in the current period.
Glossary
- us-gaap:HealthCarePremiumMember
- Represents revenue generated from health insurance premiums paid by members or government programs. (Key revenue driver for Centene, showing growth in the reported periods.)
- us-gaap:ServiceMember
- Revenue generated from services provided, distinct from premium income. (Shows growth in ancillary services, contributing to overall revenue expansion.)
- us-gaap:RetainedEarningsMember
- The cumulative amount of net income that a company has retained over time, rather than distributing to shareholders as dividends. (Indicates strong profitability as retained earnings have increased.)
- us-gaap:TreasuryStockCommonMember
- Represents shares of the company's own stock that it has repurchased from the open market. (A slight decrease suggests less aggressive share buybacks or potential use of treasury stock.)
Year-Over-Year Comparison
Centene's Q2 2025 filing shows continued revenue growth, with healthcare premiums up 3.6% year-over-year and service revenues showing a robust 9.1% increase. Retained earnings have grown, indicating strong profitability, although total equity experienced a slight decrease compared to year-end 2024. No new significant risks were highlighted in the provided summary compared to the previous period.
From the Filing
0001071739-25-000150.txt : 20250725 0001071739-25-000150.hdr.sgml : 20250725 20250724214500 ACCESSION NUMBER: 0001071739-25-000150 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 66 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250725 DATE AS OF CHANGE: 20250724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 251148406 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 10-Q 1 cnc-20250630.htm 10-Q cnc-20250630 0001071739 --12-31 2025 Q2 FALSE http://fasb.org/us-gaap/2025#OtherAssetsCurrent http://fasb.org/us-gaap/2025#OtherAssetsCurrent xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure cnc:position cnc:segment 0001071739 2025-01-01 2025-06-30 0001071739 2025-07-23 0001071739 2025-06-30 0001071739 2024-12-31 0001071739 us-gaap:HealthCarePremiumMember 2025-04-01 2025-06-30 0001071739 us-gaap:HealthCarePremiumMember 2024-04-01 2024-06-30 0001071739 us-gaap:HealthCarePremiumMember 2025-01-01 2025-06-30 0001071739 us-gaap:HealthCarePremiumMember 2024-01-01 2024-06-30 0001071739 us-gaap:ServiceMember 2025-04-01 2025-06-30 0001071739 us-gaap:ServiceMember 2024-04-01 2024-06-30 0001071739 us-gaap:ServiceMember 2025-01-01 2025-06-30 0001071739 us-gaap:ServiceMember 2024-01-01 2024-06-30 0001071739 2025-04-01 2025-06-30 0001071739 2024-04-01 2024-06-30 0001071739 2024-01-01 2024-06-30 0001071739 us-gaap:CommonStockMember 2024-12-31 0001071739 us-gaap:CommonStockMember 2025-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2025-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2024-12-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001071739 us-gaap:RetainedEarningsMember 2024-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2024-12-31 0001071739 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001071739 2025-01-01 2025-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001071739 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0001071739 us-gaap:CommonStockMember 2025-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001071739 us-gaap:RetainedEarningsMember 2025-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2025-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2025-03-31 0001071739 2025-03-31 0001071739 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001071739 us-gaap:NoncontrollingInterestMember 2025-04-01 2025-06-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0001071739 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2025-04-01 2025-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001071739 us-gaap:RetainedEarningsMember 2025-06-30 0001071739 us-gaap:NoncontrollingInterestMember 2025-06-30 0001071739 us-gaap:CommonStockMember 2023-12-31 0001071739 us-gaap:CommonStockMember 2024-06-30 0001071739 us-gaap:TreasuryStockCommonMember 2023-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2024-06-30 0001071739 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001071739 us-gaap:AccumulatedOtherComprehe